Search News

Corporate Industry Technology Medical Updates

extracorporeal ventricular assist device

Medical Updates
Bedside Echo-Guided Implantation of MoyoAssist® as a Bridge to Heart Transplantation 2025-08-20
Medical Updates
Successful Application of MoyoAssist® in Bridging to Long-Term LVAD 2025-04-09
Corporate
Redefining New Boundaries in Delivering Patient Care 2025-01-24
Industry
magAssist Showcases Next-Generation MCS Technologies at ISMCS 2024 2024-11-21
Medical Updates
MoyoAssist® Extra-VAD Introduces Fully Magnetically Levitated Extracorporeal Heart Support Technology in China 2024-06-28
Corporate
MoyoAssist® Launched! The Mid-to-Short-Term MCS Forum and Extra-VAD Clinical Technology Transformation Results Conference Successfully Held 2024-06-24
Corporate
NMPA grants approval to MoyoAssist® China's first full maglev extracorporeal VAD 2024-05-14
Industry
Dr. Po-Lin Hsu from magAssist: Nothing is More Important than Saving Lives 2022-12-21
Corporate
Dr. Po-Lin Hsu Named on List of Forbes China - 100 Outstanding Overseas Returnees 2022-12-14
Medical Updates
The FIRST transseptal cannulation treatment via MoyoAssist Extra-VAD 2022-08-24

Tabs： medical device, percutaneous intervention, Mechatronics, How to Choose Extra-VAD or ECMO, high-end medical devices, Chinese heart failure patients, cardiovascular disease patients, the extracorporeal maglev artificial heart, extracorporeal blood pumps, high-end innovative medical device,